SARAH GREEN: Open Payments
NPI 1861972424 · CEDAR RAPIDS, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$303 in 12 payments from 9 companies in 2025. Trend: 2023 $142 · 2024 $187 · 2025 $303
Food & beverage: $303
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $75 |
| Merck Sharp & Dohme LLC | 2 | $53 |
| Gilead Sciences, Inc. | 1 | $38 |
| Exelixis Inc. | 1 | $30 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Tempus AI, Inc | 1 | $25 |
| ABBVIE INC. | 1 | $19 |
| Stemline Therapeutics Inc. | 1 | $18 |
| PFIZER INC. | 1 | $14 |
Products named: Ozempic, KEYTRUDA, Trodelvy, CABOMETYX, KISQALI, XT CDX, EPKINLY, Orserdu.
Industry payments across IA — which companies pay providers there.
